Blake Madden’s Post

View profile for Blake Madden

Founder, Creator @ Hospitalogy | Breaking down the business of healthcare strategy, M&A, finance, and innovation | Building a community of healthcare strategy, operations, and finance folks in provider organizations

Great breakdown from McKinsey & Company here on current Medicare Advantage dynamics. TL;DR they have some levers but margins are as thin as they've been in recent memory in 2024. McKinsey called out the following as challenges for MA players moving forward: -Little to no rate increases from CMS -Broker commissions changes -V28 changes -Star ratings (the biggest near-term lever) -Utilization trends -Part D and other regulatory changes Source: https://lnkd.in/g9U4h2Gp

  • chart, waterfall chart
Nathan (N8) Kaufman

Managing Director at Kaufman Strategic Advisors

6mo

How about more aggressive risk scoring, increasing denials, delays, and down coding, increasing retail drug costs to increase revenues outside of the MLR formula, and capturing more rebates in offshore rebate aggregators?

Let's talk about the major flaw in the article. The pickleball players are standing in the wrong locations!

Jeff Charles Goldsmith

President, Health Futures: Fearless Forecaster, Strategist, Board Educator, Consigliere, Writer, Keynote Speaker

6mo

How about abandoning subscribers in "unprofitable" markets, and tuning up the denials and downcoding. . .

Dan Vapne PT, DPT, OCS

Creating a revolution in healthcare ✊starting with Therapy professionals 🏥🩺⚕️

6mo

I can solve this very quickly. Decrease the admin costs by removing prior auth and have broker commissions cut in half. Shouldn’t need to sell an insurance plan that makes it harder to access care. These plans have co-pays/co insurance as well which should adjust cost enough. I fixed it. But would love to hear the other side.

Like
Reply
Gabe Isaacson

Partner at McKinsey & Company

6mo

Thanks Blake for sharing. Agree with your synopsis. We’ll see how much comes out of benefits shortly…

See more comments

To view or add a comment, sign in

Explore topics